Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07184775 · ClinicalTrials.gov registry record · NA
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
A NA study of Pregnancy and Type 2 Diabetes Mellitus (T2DM), sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT07184775: Recruiting NA study of Pregnancy and Type 2 Diabetes Mellitus (T2DM), sponsored by Thomas Jefferson University.
NCT07184775 is a NA study of Pregnancy and Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 70 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07184775, a NA study of Pregnancy and Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare patient adherence to blood sugar monitoring during pregnancy using two different measurement methods in pregnancies complicated by pregestational type 2 diabetes (T2DM). Pregnant patients with T2DM are at risk of having larger babies, babies with low sugar levels in the first 24 hours of life, higher rates of cesarean delivery, stillbirth (death of baby inside the womb), and hypertensive or high blood pressure disorders of pregnancy, such as preeclampsia. Prior studies have shown that treating high blood sugars in pregnancy with medications can reduce these risks. To determine the amount of medication needed, recording of blood sugar levels is necessary. This trial aims to determine whether continuous blood sugar monitors have improved patient recording of blood sugar levels over finger stick blood sugar measurements. Patients involved in the study will be assigned to either: 1. Fingerstick glucose monitoring (FSG) 2. Continuous glucose monitoring (CGM) Patients will be randomize in a 1:1 ratio. FSG Group: blood sugar is tested four times daily - once fasting and two hours after every meal (post-prandial). Blood will be tested using a glucometer, and values will be recorded in a blood sugar log from the time of enrollment to the time of delivery. CGM Group: A CGM sensor will be placed on the patient's arm for blood sugar collection every 3-5 minutes. This data is sent to a phone application from the time of enrollment to the time of delivery. These sensors will need to be replaced every 14 days. Percent adherence will be recorded from the time you were randomized to a study group until delivery.
Primary Outcome
Compare adherence to glucose monitoring using continuous glucose monitoring versus finger stick monitoring in pregnant patients with Type 2 Diabetes
Conditions Studied
Interventions
- DEVICE Continuous glucose monitor
- DEVICE Glucometer
Study Locations (2)
New Jersey
- Jefferson Health New Jersey - Sewell
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT07184775 shows while recruiting
NCT07184775 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Continuous glucose monitor is the first listed.
NCT07184775 reports a single indexed study location in New Jersey, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07184775 about?
NCT07184775 is a clinical study titled "CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes". The purpose of this study is to compare patient adherence to blood sugar monitoring during pregnancy using two different measurement methods in pregnancies complicated by pregestational type 2 diabetes (T2DM). Pregnant patients with T2DM are at risk of having larger babies, babies with low sugar lev...
What is the current status of trial NCT07184775?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-10-01. Estimated completion is 2026-03-01.
What conditions does trial NCT07184775 study?
This clinical trial studies the following conditions: Pregnancy, Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring System.
What interventions are being tested in trial NCT07184775?
The interventions under investigation include: Continuous glucose monitor (DEVICE), Glucometer (DEVICE).
Who is sponsoring clinical trial NCT07184775?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07184775 being conducted?
This trial has 2 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07184775's enrollment target sits among peer trials
70 134th of 191 higher than 57 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
-
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI